{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:52:31Z","timestamp":1791262351217,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR\\u2014M4C2-I1.3 Project PE_00000019"],"award-info":[{"award-number":["PNRR\\u2014M4C2-I1.3 Project PE_00000019"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP I 53C22001440006"],"award-info":[{"award-number":["CUP I 53C22001440006"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376879"],"award-info":[{"award-number":["PNRR-MR1-2022-12376879"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.atherosclerosis.2026.121898","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:39:16Z","timestamp":1788417556000},"page":"121898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies"],"prefix":"10.1016","volume":"421","author":[{"given":"Filippo","family":"Biondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ghelardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashot","family":"Avagimyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121898_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13081842","article-title":"Pathophysiology of prediabetes hyperinsulinemia and insulin resistance in the cardiovascular system","volume":"13","author":"Bkaily","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","article-title":"Prediabetes and what it means: the epidemiological evidence","volume":"42","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Annu Rev Publ Health"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121898_bib3","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1210\/jc.2016-1370","article-title":"A reappraisal of prediabetes","volume":"101","author":"Davidson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(16)30328-X","article-title":"The need for international consensus on prediabetes","volume":"5","author":"Makaroff","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121898_bib5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00125-009-1443-3","article-title":"Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?","volume":"52","author":"Faerch","year":"2009","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121898_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12900","article-title":"Prevalence of prediabetes in children and adolescents by class of obesity","volume":"17","author":"Pedicelli","year":"2022","journal-title":"Pediatr Obes"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121898_bib7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40200-024-01549-6","article-title":"Prevalence and incidence of prediabetes in Latin America. A systematic review and meta-analysis","volume":"24","author":"Vera-Ponce","year":"2025","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurpub\/ckw085","article-title":"Prevalence of impaired glucose regulation in Europe: a meta-analysis","volume":"26","author":"Eades","year":"2016","journal-title":"Eur J Public Health"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib10","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/dc11-0183","article-title":"Limited overlap between intermediate hyperglycemia as defined by A1C 5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance","volume":"34","author":"Saukkonen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib11","doi-asserted-by":"crossref","unstructured":"Rooney MR, He JH, Salpea P, et al. Global and regional prediabetes prevalence: updates for 2024 and projections for 2050. Diabetes Care. Published online September 9, 2025. doi:10.2337\/dc25-1640.","DOI":"10.2337\/dc25-1640"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib12","doi-asserted-by":"crossref","unstructured":"Wagner R, Selvin E, Sehgal R, et al. Beyond glucose-rethinking prediabetes for precision prevention. Diabetes Care. Published online September 11, 2025. doi:10.2337\/dci25-0054.","DOI":"10.2337\/dci25-0054"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121898_bib13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.eprac.2024.09.008","article-title":"Prevalence, trends, and subsequent outcomes of prediabetes in the United States, 1999-2018","volume":"30","author":"Fan","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108252","article-title":"Prevalence of prediabetes and undiagnosed type 2 diabetes in France: results from the national survey ESTEBAN, 2014-2016","volume":"165","author":"Lailler","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121898_bib15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.eprac.2024.09.008","article-title":"Prevalence, trends, and subsequent outcomes of prediabetes in the United States, 1999-2018","volume":"30","author":"Fan","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/jdr\/5540276","article-title":"Incidence of prediabetes and diabetes in a European longitudinal general population cohort and its associated factors-results from the Austrian LEAD study","volume":"2025","author":"Dal Grande","year":"2025","journal-title":"J Diabetes Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000547108","article-title":"Prevalence of undiagnosed diabetes and prediabetes according to age and obesity status in central Europe","volume":"18","author":"Sourij","year":"2025","journal-title":"Obes Facts"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-01950-y","article-title":"Changes and risk factors of adult prediabetes, diabetes prevalence and diabetes control among adult residents in Xinjiang from 2010 to 2018","volume":"15","author":"Ling","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1471-2458-12-380","article-title":"Prevalence and trends of the diabetes epidemic in south Asia: a systematic review and meta-analysis","volume":"12","author":"Jayawardena","year":"2012","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069640","article-title":"Prevalence and correlates of pre-diabetes in Sub-Saharan Africa using demographic and health survey data: a cross-sectional study","volume":"13","author":"Walker","year":"2023","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121898_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21286","article-title":"Prevalence and associated factors of prediabetes in adult East African population: a systematic review and meta-analysis","volume":"9","author":"Asmelash","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121898_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41366-025-01950-y","article-title":"The prevalence of prediabetes is high and has rapidly increased, independent of the degree of obesity, in Finnish children with overweight or obesity","volume":"50","author":"Riekki","year":"2026","journal-title":"Int J Obes"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121898_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21286","article-title":"Prevalence and associated factors of prediabetes in adult East African population: a systematic review and meta-analysis","volume":"9","author":"Asmelash","year":"2023","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121898_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063318","article-title":"Association between urban-rural location and prevalence of type 2 diabetes and impaired fasting glucose in West Africa: a cross-sectional population-based epidemiological study","volume":"13","author":"Issaka","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1186\/s12889-016-3789-z","article-title":"Urban-rural and geographic differences in overweight and obesity in four sub-saharan African adult populations: a multi-country cross-sectional study","volume":"16","author":"Ajayi","year":"2016","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12905-023-02813-2","article-title":"Decomposing the rural-urban disparities in overweight and obesity among women of reproductive age in Nigeria","volume":"23","author":"Baruwa","year":"2023","journal-title":"BMC Womens Health"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121898_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph22050673","article-title":"Comorbidity prevalence in prediabetes and type 2 diabetes: a cross-sectional study in a predominantly Hispanic U.S.-mexico border population","volume":"22","author":"Noriega","year":"2025","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib28","doi-asserted-by":"crossref","unstructured":"Amani-Beni R, Darouei B, Mortaheb M, et al. Associations between anthropometric measures of obesity and prediabetes risk: a dose-response meta-analysis of cohort studies. Diabetes Obes Metab. Published online January 5, 2026. doi:10.1111\/dom.70453.","DOI":"10.1111\/dom.70453"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121898_bib29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/jdi.13783","article-title":"Association of body mass index with risk of prediabetes in Chinese adults: a population-based cohort study","volume":"13","author":"Chai","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121898_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu13031002","article-title":"Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the ILERVAS cohort","volume":"13","author":"S\u00e1nchez","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41366-022-01096-1","article-title":"Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies","volume":"46","author":"Yu","year":"2022","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib32","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/s41598-020-60153-9","article-title":"Association between dietary quality and prediabetes based on the diet balance index","volume":"10","author":"He","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14768","article-title":"Mediterranean diet and diabetes risk in a cohort study of individuals with prediabetes: propensity score analyses","volume":"39","author":"Cea-Soriano","year":"2022","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121898_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/HMBCI.2011.112","article-title":"Sex differences in the injured brain","volume":"7","author":"Melcangi","year":"2011","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib35","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3945\/jn.108.096784","article-title":"Dietary quality is associated with diabetes and cardio-metabolic risk factors","volume":"139","author":"McNaughton","year":"2009","journal-title":"J Nutr"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib36","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00125-013-3002-1","article-title":"Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German center for diabetes Research","volume":"56","author":"Wagner","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.51823","article-title":"Identifying household diabetes risk for family diabetes prevention using electronic health records","volume":"9","author":"Thomas","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines14010198","article-title":"The natural history of prediabetes and cardiovascular disease in the pediatric population","volume":"14","author":"Accacha","year":"2026","journal-title":"Biomedicines"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.121898_bib39","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.3390\/ijms26167847","article-title":"Neurotransmitter alterations in prediabetes and type 2 diabetes mellitus: a narrative review","volume":"26","author":"Ahri\u021bculesei","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11033-025-11389-z","article-title":"Molecular pathways of oxidative stress in diabetes: redox imbalance and insulin pathway dysregulation","volume":"53","author":"Wani","year":"2025","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.102052","article-title":"Diabetic cardiomyopathy: 2023 update by the International multidisciplinary board of experts","volume":"49","author":"Avagimyan","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/bjp.2008.121","article-title":"Diabetic cardiomyopathy: how much does it depend on AGE?","volume":"154","author":"Montagnani","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121898_bib43","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00201.2022","article-title":"Epigenetic modifications in metabolic memory: what are the memories, and can we erase them?","volume":"323","author":"Chen","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121898_bib44","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/genes16121442","article-title":"From metabolic to epigenetic memory: the impact of hyperglycemia-induced epigenetic signature on kidney disease progression and complications","volume":"16","author":"Cannito","year":"2025","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121898_bib45","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCRESAHA.116.306819","article-title":"Epigenetic changes in diabetes and cardiovascular risk","volume":"118","author":"Keating","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCGENETICS.114.000671","article-title":"Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus","volume":"8","author":"Paneni","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13098-026-02129-9","article-title":"Beyond hyperglycemia: histone modification-mediated epigenetic dysregulation in diabetic retinopathy and nephropathy","volume":"18","author":"Tang","year":"2026","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121898_bib48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/db08-1666","article-title":"Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail","volume":"58","author":"Brasacchio","year":"2009","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.121898_bib49","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms22136964","article-title":"Chronic and transient hyperglycemia induces changes in the expression patterns of IL6 and ADIPOQ genes and their associated epigenetic modifications in differentiating human visceral adipocytes","volume":"22","author":"Wr\u00f3blewski","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121898_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101156","article-title":"The pathophysiological basis of diabetic cardiomyopathy development","volume":"47","author":"Avagimyan","year":"2022","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib51","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1152\/ajpendo.00471.2005","article-title":"Influence of TNF-\u03b1 and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans","volume":"291","author":"Krogh-Madsen","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1113\/EP089947","article-title":"Zucker diabetic-Sprague Dawley (ZDSD) rat: type 2 diabetes translational research model","volume":"107","author":"Wang","year":"2022","journal-title":"Exp Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121898_bib53","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/nu13051666","article-title":"Distinct effects of a high fat diet on bone in skeletally mature and developing Male C57BL\/6J mice","volume":"13","author":"Ross","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib54","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0300985813501335","article-title":"Phenotypic characterization of the KK\/HlJ inbred mouse strain","volume":"51","author":"Berndt","year":"2014","journal-title":"Vet Pathol"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2019.112646","article-title":"Strain and sex-based glucocentric & behavioral differences between KK\/HlJ and C57BL\/6J mice","volume":"210","author":"Inglis","year":"2019","journal-title":"Physiol Behav"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102242","article-title":"DYRK1A inhibition restores pancreatic functions and improves glucose metabolism in a preclinical model of type 2 diabetes","volume":"101","author":"Bertrand","year":"2025","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/JOE-20-0439","article-title":"Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats","volume":"248","author":"Saiyasit","year":"2021","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121898_bib58","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/JOE-17-0516","article-title":"Mechanisms of \u03b2-cell dedifferentiation in diabetes: recent findings and future research directions","volume":"236","author":"Bensellam","year":"2018","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib59","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048909","article-title":"Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model","volume":"14","author":"Elzinga","year":"2021","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110185","article-title":"Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance","volume":"194","author":"Succurro","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.691823","article-title":"Pre-Diabetes increases tuberculosis disease severity, while high body fat without impaired glucose tolerance is protective","volume":"11","author":"Sinha","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115951","article-title":"Interaction of serotonin\/GLP-1 circuitry in a dual preclinical model for psychiatric disorders and metabolic dysfunction","volume":"337","author":"Kolling","year":"2024","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121898_bib63","doi-asserted-by":"crossref","first-page":"e1533","DOI":"10.1016\/S2214-109X(25)00237-2","article-title":"Prediabetes transitions to normoglycaemia or type 2 diabetes and associated risk factors in the obesity, diabetes and cardiovascular disease collaboration: an individual-level pooled analysis of 19 prospective cohort studies","volume":"13","author":"Davoodian","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121898_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001529","article-title":"Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American diabetes association and world health organization diagnostic criteria","volume":"8","author":"van Herpt","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121898_bib65","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-013-2902-4","article-title":"Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis","volume":"56","author":"Morris","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000794","article-title":"Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes","volume":"7","author":"Lee","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the atherosclerosis risk in communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib68","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1186\/s12889-025-21404-4","article-title":"Risk factors for progression to type 2 diabetes in prediabetes: a systematic review and meta-analysis","volume":"25","author":"Hu","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132663","article-title":"Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine","volume":"418","author":"Avagimyan","year":"2025","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12944-024-02239-1","article-title":"A longitudinal study on the impact of the TyG index and TG\/HDL-C ratio on the risk of type 2 diabetes in Chinese patients with prediabetes","volume":"23","author":"Chen","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121898_bib71","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20253283","article-title":"miRNAs as potential biomarkers for early detection of prediabetes among obesity: a systematic review","volume":"45","author":"Keng-Lim","year":"2025","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib72","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41598-017-06309-6","article-title":"Metabolic biomarkers for prognostic prediction of Pre-diabetes: results from a longitudinal cohort study","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib73","article-title":"Potential novel serum metabolic markers associated with progression of prediabetes to overt diabetes in a Chinese population","volume":"12","author":"Ren","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2_suppl","key":"10.1016\/j.atherosclerosis.2026.121898_bib74","article-title":"Lifestyle interventions for treatment and remission of type 2 diabetes and prediabetes in adults: a clinical practice guideline from the American college of lifestyle medicine","volume":"19","author":"Rosenfeld","year":"2025","journal-title":"Am J Lifestyle Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121898_bib75","article-title":"Core exercise as non-pharmacological strategy for improving metabolic health in prediabetic women","volume":"61","author":"Yi\u011fiter","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13954","article-title":"Comparative efficacy of exercise type on visceral adipose tissue in patients with prediabetes and type 2 diabetes mellitus: a systematic review with pairwise and network meta-analyses","author":"Khalafi","year":"2025","journal-title":"Obes Rev"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib77","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4093\/dmj.2022.0265","article-title":"Effects of exercise training and chlorogenic acid supplementation on hepatic lipid metabolism in prediabetes mice","volume":"47","author":"Shirkhani","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112948","article-title":"Accelerometer-measured \u201cweekend warrior\u201d physical activity and incident cardiovascular disease in adults with type 2 diabetes mellitus or prediabetes: a prospective cohort study","volume":"229","author":"Yang","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib79","first-page":"96","article-title":"Prediabetes: to be treated or not?","volume":"73","author":"Agrawal","year":"2025","journal-title":"J Assoc Physicians India"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121898_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10081162","article-title":"Blueberry as an attractive functional fruit to prevent (Pre)Diabetes progression","volume":"10","author":"Nunes","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1639901","article-title":"Citrus flavonoid supplement enhances glycemic and metabolic control in prediabetic patients on metformin: a randomized controlled trial","volume":"12","author":"Cesar","year":"2025","journal-title":"Front Nutr"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/nu16040513","article-title":"Effect of blueberry supplementation on a diet-induced rat model of prediabetes-focus on hepatic lipid deposition, endoplasmic stress response and autophagy","volume":"16","author":"Ferreira","year":"2024","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121898_bib83","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1002\/fsn3.3654","article-title":"Lemon flavonoids nutraceutical (Eriomin\u00ae) attenuates prediabetes intestinal dysbiosis: a double-blind randomized controlled trial","volume":"11","author":"Ramos","year":"2023","journal-title":"Food Sci Nutr"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.121898_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204777","article-title":"Plasma and urinary (poly)phenolic profiles after 4-Week red raspberry (Rubus idaeus L.) intake with or without fructo-oligosaccharide supplementation","volume":"25","author":"Zhang","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib85","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/jn\/nxac037","article-title":"Red raspberry and fructo-oligosaccharide supplementation, metabolic biomarkers, and the gut microbiota in adults with prediabetes: a randomized crossover clinical trial","volume":"152","author":"Zhang","year":"2022","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121898_bib86","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3390\/nu18121968","article-title":"Polyphenols and cardiovascular health: emerging relevance for blueberries, grapes, and red-fleshed table grapes","volume":"18","author":"Derbyshire","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib87","series-title":"Natural products to promote vascular health","first-page":"33","author":"Schini-Kerth","year":"2025"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40200-023-01326-x","article-title":"Polyphenols mediated attenuation of diabetes associated cardiovascular complications: a comprehensive review","volume":"23","author":"Kour","year":"2023","journal-title":"J Diabetes Metab Disord"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib89","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/nu17101630","article-title":"The role of nutraceuticals and probiotics in addition to lifestyle intervention in the management of childhood obesity\u2014part 1: metabolic changes","volume":"17","author":"Street","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2025.108007","article-title":"Protocol for a randomized controlled trial to evaluate the impact of daily supplementation with zinc, chromium, vitamin C, and copper on progression of prediabetes in Jakarta, Indonesia","volume":"156","author":"Agustina","year":"2025","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clnu.2025.07.006","article-title":"Hydroxytyrosol supplementation improves antioxidant and anti-inflammatory status in individuals with overweight and prediabetes: a randomized, double-blind, placebo-controlled parallel trial","volume":"52","author":"Moratilla-Rivera","year":"2025","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12906-025-05034-2","article-title":"The interaction of vitamin D supplementation with Omentin-1 gene polymorphism on metabolic factors and anthropometric indices in women with prediabetes: a study protocol for a double-blind randomized controlled trial","volume":"25","author":"Molani-Gol","year":"2025","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41387-025-00386-7","article-title":"The effect of turmeric\/curcumin supplementation on anthropometric indices in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials","volume":"15","author":"Moradi","year":"2025","journal-title":"Nutr Diabetes"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40200-025-01853-9","article-title":"Impact of oral magnesium supplementation on glycemic and cardiometabolic outcomes in prediabetic adults: a systematic review and meta-analysis","volume":"25","author":"Basit","year":"2026","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib95","doi-asserted-by":"crossref","DOI":"10.1186\/s40795-026-01424-y","article-title":"Oral magnesium supplements and insulin resistance in individuals with diabetes and pre-diabetes: an updated systematic review and meta-analysis of randomized controlled trials","author":"Amiri","year":"2026","journal-title":"BMC Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib96","article-title":"Oral magnesium supplementation improves glycemic control in older Chinese adults with pre-diabetes and hypomagnesemia: a randomized controlled trial","volume":"13","author":"Yang","year":"2026","journal-title":"Front Nutr"},{"issue":"Supplement_1","key":"10.1016\/j.atherosclerosis.2026.121898_bib97","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.2337\/dc26-S003","article-title":"3. Prevention or delay of diabetes and associated comorbidities: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121898_bib98","first-page":"CD008558","article-title":"Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus","volume":"12","author":"Madsen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.09.004","article-title":"Prediabetes and cardiovascular disease risk: a nested case-control study","volume":"278","author":"Hu","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.athplu.2023.08.002","article-title":"Prediabetes is an incremental risk factor for adverse cardiac events: a nationwide analysis","volume":"54","author":"Nanavaty","year":"2023","journal-title":"Atherosclerosis Plus"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib101","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib102","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12889-024-17996-y","article-title":"Prevalence of prediabetes and risk of CVD mortality in individuals with prediabetes alone or plus hypertension in Northeast China: insight from a population based cohort study","volume":"24","author":"Yue","year":"2024","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121898_bib103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/dc18-1773","article-title":"Long-term absolute risk for cardiovascular disease stratified by fasting glucose level","volume":"42","author":"Bancks","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib104","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1038\/s41467-020-18386-9","article-title":"An investigation of causal relationships between prediabetes and vascular complications","volume":"11","author":"Mutie","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121898_bib105","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/dom.14686","article-title":"Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: a community-based study","volume":"24","author":"Williams","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib106","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib107","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2023.07.012","article-title":"Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes","volume":"265","author":"Williams","year":"2023","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib108","doi-asserted-by":"crossref","DOI":"10.1177\/14791641231188704","article-title":"Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999-2018","volume":"20","author":"Zhang","year":"2023","journal-title":"Diab Vasc Dis Res"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2026.121898_bib109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11739-011-0669-5","article-title":"The epidemiological concept of residual risk","volume":"6","author":"Vanuzzo","year":"2011","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejim.2023.10.013","article-title":"Residual cardiovascular risk: when should we treat it?","volume":"120","author":"Gomez-Delgado","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2026.121898_bib111","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109219","article-title":"Historical review of the diagnosis of prediabetes\/intermediate hyperglycemia: case for the international criteria","volume":"185","author":"Davidson","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/met.2023.0005","article-title":"The role of prediabetes in the metabolic syndrome: guilt by association","volume":"21","author":"Davidson","year":"2023","journal-title":"Metab Syndr Relat Disord"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib114","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s13300-023-01449-7","article-title":"Should prediabetes be treated pharmacologically?","volume":"14","author":"Davidson","year":"2023","journal-title":"Diabetes Ther"},{"issue":"48","key":"10.1016\/j.atherosclerosis.2026.121898_bib115","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1093\/eurheartj\/ehae533","article-title":"Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction","volume":"45","author":"Marx","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib116","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.ijcard.2013.05.038","article-title":"Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study","volume":"168","author":"Deedwania","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121898_bib117","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/HYPERTENSIONAHA.114.04632","article-title":"Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus","volume":"65","author":"Qiu","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-020-01017-4","article-title":"Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran lipid and glucose study","volume":"19","author":"Kabootari","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib119","article-title":"Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis","volume":"370","author":"Cai","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001776","article-title":"Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis","volume":"9","author":"Gujral","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib121","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.121898_bib122","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCULATIONAHA.121.056756","article-title":"Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study","volume":"145","author":"Goldberg","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121898_bib123","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41416-022-02038-4","article-title":"The importance of long-term follow up of participants in clinical trials","volume":"128","author":"Cuzick","year":"2023","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib124","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00125-004-1409-4","article-title":"Acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM trial data","volume":"47","author":"Chiasson","year":"2004","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-Year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1741826711421687","article-title":"Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials","volume":"18","author":"Hopper","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1294819","article-title":"Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies","volume":"15","author":"An","year":"2024","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/jcdd13010033","article-title":"Metformin beyond glycemic control: cardiovascular protection and diabetes prevention","volume":"13","author":"Zakynthinos","year":"2026","journal-title":"J Cardiovasc Dev Dis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121898_bib129","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121898_bib130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00125-008-0951-x","article-title":"Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action","volume":"51","author":"Faerch","year":"2008","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121898_bib131","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/aje\/kwac019","article-title":"Casting new light on statistical power: an illuminating analogy and strategies to avoid underpowered trials","volume":"191","author":"Kiernan","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121898_bib132","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S2213-8587(23)00132-8","volume":"11","author":"Zhang","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121898_bib133","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2337\/dc25-1555","article-title":"Effectiveness of an incentives-enhanced stepped care Intervention Program in diabetes prevention in a multiethnic Asian prediabetes cohort: results from the Pre-DICTED randomized controlled trial","volume":"48","author":"Bee","year":"2025","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib134","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"issue":"10077","key":"10.1016\/j.atherosclerosis.2026.121898_bib135","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121898_bib136","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-8587(24)00182-7","article-title":"Efficacy and safety of once-weekly semaglutide 2\u00b74 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial","volume":"12","author":"McGowan","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib137","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/db23-0356","article-title":"Weight loss-independent effect of liraglutide on insulin sensitivity in individuals with obesity and prediabetes","volume":"73","author":"Mashayekhi","year":"2024","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121898_bib138","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00125-013-3134-3","article-title":"Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study","volume":"57","author":"Kim","year":"2014","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3892\/etm.2023.11948","article-title":"Effect of liraglutide on atherosclerosis in patients with impaired glucose tolerance: a double-blind, randomized controlled clinical trial","volume":"25","author":"Sun","year":"2023","journal-title":"Exp Ther Med"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib140","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.2337\/dc13-0354","article-title":"Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278685","article-title":"Effect of glucagon-like peptide-1 receptor agonists on glycemic control, and weight reduction in adults: a multivariate meta-analysis","volume":"18","author":"Yeh","year":"2023","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib142","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/dom.12660","article-title":"Relationship between weight change and glycaemic control in patients with type 2 diabetes receiving once-weekly dulaglutide treatment","volume":"18","author":"Umpierrez","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121898_bib143","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1111\/dom.16592","article-title":"HbA1c reduction with tirzepatide in people with type 2 diabetes: the contribution of weight loss assessed by a mediation analysis","volume":"27","author":"Vilsb\u00f8ll","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib144","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1370\/afm.1946","article-title":"Prevalence of prediabetes and abdominal obesity among healthy-weight adults: 18-year trend","volume":"14","author":"Mainous","year":"2016","journal-title":"Ann Fam Med"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2026.121898_bib145","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"Supplement_1","key":"10.1016\/j.atherosclerosis.2026.121898_bib146","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc26-SINT","article-title":"Introduction and methodology: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"37","key":"10.1016\/j.atherosclerosis.2026.121898_bib147","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155396","article-title":"Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: a randomized, double-blind crossover trial","volume":"140","author":"Veelen","year":"2023","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121898_bib149","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/dc21-1136","article-title":"Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: a randomized, double-blind, placebo-controlled, phase 2 trial","volume":"45","author":"Kullmann","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib150","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/s41467-020-15686-y","article-title":"Brain insulin sensitivity is linked to adiposity and body fat distribution","volume":"11","author":"Kullmann","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib151","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00125-020-05306-1","article-title":"The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or Obese individuals with prediabetes (the PRE-D trial): a multi-arm, randomised, controlled trial","volume":"64","author":"F\u00e6rch","year":"2021","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121898_bib152","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MBP.0000000000000479","article-title":"Effects of dapagliflozin on blood pressure variability in patients with prediabetes and prehypertension without pharmacological treatment: a randomized trial","volume":"25","author":"D\u00edaz-Cruz","year":"2020","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.atherosclerosis.2026.121898_bib153","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"Extraglycemic effects of SGLT2 inhibitors: a review of the evidence","volume":"13","author":"Bonora","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.121898_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121898_bib156","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/clinem\/dgac591","article-title":"Sodium-glucose cotransporter 2 inhibitors and new-onset type 2 diabetes in adults with prediabetes: systematic review and meta-analysis of randomized controlled trials","volume":"108","author":"Mori","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.121898_bib157","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.121898_bib158","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.121898_bib159","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121898_bib160","first-page":"363","article-title":"Treating prediabetes with metformin: systematic review and meta-analysis","volume":"55","author":"Lily","year":"2009","journal-title":"Can Fam Physician"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:17:20Z","timestamp":1791260240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026012645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":159,"alternative-id":["S0021915026012645"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121898","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121898"}}